The fasting concentrations and iAUC of glucagon after both meal tests were numerically lower with oral semaglutide than placebo, but the difference did not reach statistical significance, which is likely to be because of the small number of subjects in the trial.
← all excerpts
Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes.
1
—
—